Shanghai Cohort Study of Diabetic Eye Disease

Last updated: September 6, 2018
Sponsor: Shanghai Eye Disease Prevention and Treatment Center
Overall Status: Active - Enrolling

Phase

N/A

Condition

Macular Edema

Diabetic Retinopathy

Treatment

N/A

Clinical Study ID

NCT03665090
YFZX2018007
  • Ages > 35
  • All Genders

Study Summary

To describe the design, methodology and baseline characteristics of the Shanghai Cohort study of Diabetic Eye disease (SCODE) study, a community-based study to determine the prevalence and impact of diabetic eye disease, especially diabetic retinopathy (DR), in adults with diabetes living in Shanghai.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adults with diabetes aged 35 years and above; under archives management; residing inShanghai.

Exclusion

Exclusion Criteria:

  • All the study participants have difficulties of mobility or communication.

Study Design

Total Participants: 8000
Study Start date:
January 01, 2016
Estimated Completion Date:
December 31, 2020

Study Description

The Shanghai Cohort study of Diabetic Eye disease (SCODE) was a three-year community-based study to carry out a regular ocular health screening and epidemiological analysis for diabetic eye disease in the approximately 8,000 middle-aged and elderly people with diabetes in Shanghai. Through this study, we hope to understand the prevalence, epidemic trend and the features of risk factors distribution on diabetic eye disease, especially on DR.

Meanwhile, our aims also included estimating the ocular fundus changes and visual impairment associated with different grade of DR. Furthermore, the aim of the present study was to investigate the association between serum and urine biochemical parameters and DR.